1st Quarter - Report

THE MCMANUS GROUP for GENENTECH

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to comparative effectiveness. S. 2029, "Physician Payments Sunshine Act of 2007," all provisions.

LobbyistCovered position, as disclosed
JOHN MCMANUS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2029 (110th)

Pharmacy PHA

H.R. 1038, "Access to Life-Savings Medicine Act," all provisions. H.R. 5629, "Pathway for Biosimilars Act," all provisions.

LobbyistCovered position, as disclosed
JOHN MCMANUS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5629 (110th), H.R. 1038 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.